The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders

Authors: Bureau, AlexandreBeaulieu, Jean MartinPaccalet, ThomasChagnon, Yvon C.Maziade, Michel
Abstract: Background: Previous evidence in healthy subjects suggested that functional polymorphisms GSK3B rs12630592 and FXR1 rs496250 interact in regulating mood and emotional processing. We attempted to replicate this interaction primarily on manic and depressive dimensions in mood disorder patients, and secondarily on schizophrenia patients, diagnosis itself and age of onset. Methods : Symptom dimensions were derived from the Comprehensive Assessment of Symptoms and History 82 items rated lifetime in acute episodes and stabilized interepisode intervals in 384 patients from the Schizophrenia and Bipolar Disorder Eastern Quebec Kindred Study. Linear mixed effect models of symptom dimensions included rs12630592-rs496250 main and interaction fixed effects (obtained from TaqMan genotypes), and a polygenic random effect. The distribution of lifetime best-estimate DSM-IV diagnosis of 855 kindred members was studied versus genotype under a polytomous logistic model. Results : In mood disorder patients, the level of mania (in both acute and stabilized periods) and depression in stabilized periods was positively associated with GSK3B rs12630592 T only in FXR1 rs496250 A-allele carriers (Bonferroni-corrected interaction p=0.024, 0.052 and 0.017 respectively). The two polymorphisms explained 11% of mania variance and 5% of interepisode depression variance. The association was observed neither in schizophrenia patients nor with the psychotic dimension in mood disorder patients. Interaction with the diagnosis distribution (p=0.03) was driven by the decreasing prevalence of recurrent major depression with rs12630592 T also only in carriers of rs496250 A. Limitations : Sample size was limited, but power was sufficient to detect the tested interaction effect in this replication sample. Conclusions : We replicate in affective patients an interaction between the FXR1 rs496250 and GSK3B rs12630592 polymorphisms in regulating mood dimensions.
Document Type: Article de recherche
Issue Date: 16 February 2017
Open Access Date: 16 February 2018
Document version: AM
This document was published in: Journal of affective disorders, Vol. 213, 172–177 (2017)
Alternative version: 10.1016/j.jad.2017.02.023
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Bureau et al JAD revision final.docx99.22 kBMicrosoft Word XMLView/Open
figsup1.pdf26.86 kBAdobe PDFThumbnail
figsup2.pdf32.46 kBAdobe PDFThumbnail
figsup3.pdf27.65 kBAdobe PDFThumbnail
figsup4.pdf27.95 kBAdobe PDFThumbnail
Figure1.pdf47.61 kBAdobe PDFThumbnail
Figure2.pdf5.04 kBAdobe PDFThumbnail
FigureS5.pdf13.14 kBAdobe PDFThumbnail
SupplementaryFiguresLegends.docx77.34 kBMicrosoft Word XMLView/Open
SupplementaryMaterial_JAD.docx136.59 kBMicrosoft Word XMLView/Open
Table1.docx83.18 kBMicrosoft Word XMLView/Open
TableS1.docx45.31 kBMicrosoft Word XMLView/Open
TableS2.docx37.46 kBMicrosoft Word XMLView/Open
All documents in CorpusUL are protected by Copyright Act of Canada.